Clopidogrel Transdermal

Clopidogrel Transdermal (e.g., Gel/Cream)
Usage
Clopidogrel transdermal is a compounded formulation designed to deliver an antiplatelet agent through the skin for systemic effect when oral administration is not suitable.
It may be considered for:
• Prevention of atherothrombotic events (e.g., stroke, myocardial infarction) in patients who cannot take oral medication
• Situations requiring alternative administration routes due to swallowing difficulties or intolerance to oral dosage forms
• Veterinary applications, particularly in species where oral dosing is challenging
• Other practitioner-directed uses where transdermal antiplatelet therapy is appropriate
Use should be under the supervision of a qualified healthcare professional, with careful assessment of risks and benefits.

Dosage
Dosage should be determined by the prescribing practitioner based on the patient’s condition, weight, and clinical response.
Typical dosing considerations include:
• Apply a measured amount of gel/cream once daily, or as directed
• Apply to clean, intact skin at a recommended site (e.g., inner arm or other suitable area)
• Rotate application sites to reduce local irritation
• Wash hands after application
Because transdermal absorption may vary, dosing may require individual titration and monitoring.

Mechanisms of Action
Clopidogrel is an antiplatelet agent that inhibits platelet aggregation.
Its mechanisms include:
Irreversible inhibition of P2Y₁₂ receptors
Clopidogrel (after metabolic activation) blocks the adenosine diphosphate (ADP) P2Y₁₂ receptor on platelets.
Prevention of platelet activation and aggregation
This inhibits the activation of the glycoprotein IIb/IIIa complex, reducing platelet aggregation.
Reduction in thrombus formation
By preventing platelet clumping, clopidogrel reduces the risk of arterial thrombosis.
With transdermal use, clopidogrel is absorbed through the skin and exerts systemic antiplatelet effects.

Contraindications
Clopidogrel transdermal should not be used in patients with:
• Hypersensitivity to clopidogrel or any component of the formulation
• Active pathological bleeding, such as gastrointestinal bleeding or intracranial haemorrhage
• Conditions associated with a high risk of bleeding

Precautions
Clopidogrel should be used with caution in patients with:
• Increased risk of bleeding (e.g., trauma, surgery, coagulation disorders)
• Hepatic impairment
• Renal impairment
• Concurrent use of medications that increase bleeding risk (e.g., anticoagulants, NSAIDs)
Additional considerations include:
• Monitor for signs of bleeding, including bruising, nosebleeds, or gastrointestinal bleeding
• Transdermal absorption may be variable, requiring clinical monitoring
• Avoid application to broken or irritated skin, which may increase systemic absorption
• Patients should inform healthcare providers before undergoing surgical or dental procedures
Patients should seek medical attention if they experience unusual bleeding, black stools, blood in urine, or prolonged bleeding.

Storage
• Store below 25°C unless otherwise directed
• Keep the container tightly closed when not in use
• Protect from heat, moisture, and direct light
• Do not freeze unless specifically instructed
• Keep out of reach of children and pets
Patients should follow the specific storage instructions provided on the dispensing label supplied by the pharmacy.